Table 1.
Patient demographics and clinicopathological data.
Figure 1.
Receiver operating characteristics curves for Mcm5 and NMP22 tests for the detection of bladder cancer in all studied patients with valid test results.
Table 2.
Performance of Mcm5 and NMP22 tests for bladder carcinoma detection for all patients with test results available.
Table 3.
False positive rates for the Mcm5 and NMP22 tests across benign conditions.
Table 4.
Comparison of Mcm5 and NMP22 test performance across grade and stage.